Herlev Hospital Report issue

Academic/Hospital Phase 1 Phase 3 Phase 4

Organization Overview

First Clinical Trial
2011
NCT01355523
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2021

Timeline

NOW
  • Now

Alternative names

Inge Høgh Dufva | Inna Chen, MD | Jens Faber | Lars Peter Holst Andersen | Melissa Voigt Hansen